Registration of securities issued in business combination transactions

Restatement of Previously Issued Financial Statements (Details) - Schedule of the restatement on each financial statement

v3.21.1
Restatement of Previously Issued Financial Statements (Details) - Schedule of the restatement on each financial statement - USD ($)
 3 Months Ended 8 Months Ended 11 Months Ended
Sep. 30, 2020
Sep. 30, 2020
Dec. 31, 2020
As Previously Reported [Member]      
Condensed Financial Statements, Captions [Line Items]      
Warrant Liability
Class A common stock subject to possible redemption 163,128,000 163,128,000 162,293,000
Additional paid-in capital 5,121,000 5,121,000 5,951,000
Retained earnings (accumulated deficit) (2,000) (2,000) (951,000)
Statement of Operations for the Period from January 24, 2020 (inception) to December 31, 2020 (audited)      
Other expense – Costs of issuance of warrants    
Other expense – Change in value of warrant liability    
Total other income (expense)   26,000 79,000
Other income – Change in value of warrant liability    
Other income – Costs of issuance of warrants    
Net income (loss) $ (119,000) $ (121,000) $ (951,000)
Net income (loss) per Class B common share (in Dollars per share) $ (0.03) $ (0.03) $ (0.24)
Statement of Cash Flows for the Period from January 24, 2020 (inception) to December 31, 2020 (audited)      
Cost of warrant issuance included in financing activities  
Change in fair value of warrant liability  
Adjustments [Member]      
Condensed Financial Statements, Captions [Line Items]      
Warrant Liability 10,948,000 $ 10,948,000 10,948,000
Class A common stock subject to possible redemption 9,468,000 9,468,000 (10,948,000)
Additional paid-in capital 390,000 390,000 390,000
Retained earnings (accumulated deficit) (390,000) (390,000) (390,000)
Statement of Operations for the Period from January 24, 2020 (inception) to December 31, 2020 (audited)      
Other expense – Costs of issuance of warrants     (390,000)
Other expense – Change in value of warrant liability     (10,571,000)
Total other income (expense)   1,090,000 (390,000)
Other income – Change in value of warrant liability 1,480,000 1,480,000  
Other income – Costs of issuance of warrants (390,000) (390,000)  
Net income (loss) $ 1,090,000 $ 1,480,000 $ (390,000)
Net income (loss) per Class B common share (in Dollars per share) $ 0.26 $ 0.25 $ (2.73)
Statement of Cash Flows for the Period from January 24, 2020 (inception) to December 31, 2020 (audited)      
Cost of warrant issuance included in financing activities $ (390,000) $ (390,000) $ (390,000)
Change in fair value of warrant liability (1,480,000) (1,480,000) (10,571,000)
Restated [Member]      
Condensed Financial Statements, Captions [Line Items]      
Warrant Liability 9,468,000 9,468,000 21,519,000
Class A common stock subject to possible redemption 153,660,000 153,660,000 140,774,000
Additional paid-in capital 4,031,000 4,031,000 16,912,000
Retained earnings (accumulated deficit) 969,000 969,000 (11,912,000)
Statement of Operations for the Period from January 24, 2020 (inception) to December 31, 2020 (audited)      
Other expense – Costs of issuance of warrants     (390,000)
Other expense – Change in value of warrant liability     (10,571,000)
Total other income (expense)   1,116,000 (10,882,000)
Other income – Change in value of warrant liability 1,480,000 1,480,000  
Other income – Costs of issuance of warrants (390,000) (390,000)  
Net income (loss) $ 971,000 $ 969,000 $ (11,912,000)
Net income (loss) per Class B common share (in Dollars per share) $ 0.23 $ 0.22 $ (2.97)
Statement of Cash Flows for the Period from January 24, 2020 (inception) to December 31, 2020 (audited)      
Cost of warrant issuance included in financing activities $ (390,000) $ (390,000) $ (390,000)
Change in fair value of warrant liability $ (1,480,000) $ (1,480,000) $ (10,571,000)